Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 3 | |
Outperform | 6 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in JPY
The 10 analysts offering 12 month price targets for Nxera Pharma Co Ltd have a median target of 1,850.00, with a high estimate of 3,900.00 and a low estimate of 1,300.00. The median estimate represents a 63.43% increase from the last price of 1,132.00.
High | 244.5% | 3,900.00 |
Med | 63.4% | 1,850.00 |
Low | 14.8% | 1,300.00 |
Dividends in JPY
Div growth (TTM) | -- |
---|
More ▼
Earnings history & estimates in JPY
The next earnings announcement is expected on Feb 11, 2025.
Average growth rate | -489.59% |
Average growth rate | -29.51% |
More ▼
Revenue history & estimates in JPY
Average growth rate | +43.11% |
Average growth rate | +15.28% |
More ▼